Here are five points:
1. Five analysts rated Tenet’s stock as “buy,” five analysts rated it as “outperform,” and 11 analysts rated it as “hold.”
2. Analysts gave a consensus estimate of $0.35 a share.
3. For this quarter, Tenet expects revenue to hit $4.79 billion, up from $4.43 billion the same period last year.
4. Some analysts project the 12-month average price target to hit $65, indicating a 143 percent upside potential from the closing price of $26.72.
5. Other analysts predict a $23 price target for the shares, however.
More articles on transaction & valuation:
East Coast Surgery Center gets building permit on $3.56M project: 5 key notes
What do you really know about your investment advisor? Avoid choosing the wrong firm for you
3 quick notes on AmSurg’s quarterly dividend
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
